Werkgroep Cardiologische centra Nederland

OCEANIC-AF (Follow-up)

Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group phase III study of the oral FXIa inhibitor BAY 2433334 for the prevention of stroke or systemic embolism in patients with atrial fibrillation
Medicine
FXIa inhibitor BAY 2433334
Population
Arrhythmia
Phase
III
Starting year
2021